Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Progression of pulse pressure in kidney recipients durably exposed to CsA is a risk factor for epithelial phenotypic changes: an ancillary study of the CONCEPT trial.
Xu-Dubois YC, Hertig A, Lebranchu Y, Hurault de Ligny B, Thervet E, Jauréguy M, Touchard G, Le Pogamp P, Le Meur Y, Toupance O, Heng AE, Bayle F, Girardot-Seguin S, Servais A, Meas-Yedid V, Rondeau E. Xu-Dubois YC, et al. Among authors: lebranchu y. Transpl Int. 2014 Apr;27(4):344-52. doi: 10.1111/tri.12253. Epub 2014 Jan 28. Transpl Int. 2014. PMID: 24279707 Free article. Clinical Trial.
Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation.
Gatault P, Bertrand D, Büchler M, Colosio C, Hurault de Ligny B, Weestel PF, Rerolle JP, Thierry A, Sayegh J, Moulin B, Snanoudj R, Rivalan J, Heng AE, Sautenet B, Lebranchu Y. Gatault P, et al. Among authors: lebranchu y. Transpl Int. 2016 Jan;29(1):41-50. doi: 10.1111/tri.12656. Transpl Int. 2016. PMID: 26285161 Free article. Clinical Trial.
Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus.
Servais A, Meas-Yedid V, Toupance O, Lebranchu Y, Thierry A, Moulin B, Etienne I, Presne C, Hurault de LB, Le Pogamp P, Le Meur Y, Glotz D, Hayem C, Olivo Marin JC, Thervet E. Servais A, et al. Among authors: lebranchu y. Am J Transplant. 2009 Nov;9(11):2552-60. doi: 10.1111/j.1600-6143.2009.02803.x. Am J Transplant. 2009. PMID: 19843033 Free article. Clinical Trial.
Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.
Lebranchu Y, Bridoux F, Büchler M, Le Meur Y, Etienne I, Toupance O, Hurault de Ligny B, Touchard G, Moulin B, Le Pogamp P, Reigneau O, Guignard M, Rifle G. Lebranchu Y, et al. Am J Transplant. 2002 Jan;2(1):48-56. doi: 10.1034/j.1600-6143.2002.020109.x. Am J Transplant. 2002. PMID: 12095056 Free article. Clinical Trial.
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients.
Charpentier B, Rostaing L, Berthoux F, Lang P, Civati G, Touraine JL, Squifflet JP, Vialtel P, Abramowicz D, Mourad G, Wolf P, Cassuto E, Moulin B, Rifle G, Pruna A, Merville P, Mignon F, Legendre C, Le Pogamp P, Lebranchu Y, Toupance O, Hurault De Ligny B, Touchard G, Olmer M, Purgus R, Pouteil-Noble C, Glotz D, Bourbigot B, Leski M, Wauters JP, Kessler M. Charpentier B, et al. Among authors: lebranchu y. Transplantation. 2003 Mar 27;75(6):844-51. doi: 10.1097/01.TP.0000056635.59888.EF. Transplantation. 2003. PMID: 12660513 Clinical Trial.
Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil.
Le Meur Y, Thierry A, Glowacki F, Rerolle JP, Garrigue V, Ouali N, Heng AE, Delahousse M, Albano L, Lang P, Couzi L, Jaureguy M, Lebranchu Y, Mousson C, Glotz D, Kessler M, Vrtovsnik F, Rouanet S, Tagieva N, Kamar N. Le Meur Y, et al. Among authors: lebranchu y. Transplantation. 2011 Dec 15;92(11):1244-51. doi: 10.1097/TP.0b013e318234e134. Transplantation. 2011. PMID: 22067312 Clinical Trial.
Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids.
Büchler M, Caillard S, Barbier S, Thervet E, Toupance O, Mazouz H, Hurault de Ligny B, Le Meur Y, Thierry A, Villemain F, Heng AE, Moulin B, Morin MP, Noël C, Lebranchu Y; SPIESSER Group. Büchler M, et al. Among authors: lebranchu y. Am J Transplant. 2007 Nov;7(11):2522-31. doi: 10.1111/j.1600-6143.2007.01976.x. Epub 2007 Sep 14. Am J Transplant. 2007. PMID: 17868057 Free article. Clinical Trial.
284 results